GRAL — GRAIL, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1699031 ·
Last close
$59.81
Market Cap
$2.57B
52W High
$79.50
52W Low
$44.06
ADV30
788,002
Next earnings
2026-05-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 40,785,000 | -14,307,000 | -135,765,000 | -93,187,000 | 2,803,474,000 | 69,344,000 | 302,788,000 |
| Dec 2025 | 43,597,000 | -11,136,000 | -124,411,000 | -99,176,000 | 2,922,015,000 | 249,727,000 | 344,153,000 |
| Sep 2025 | 36,194,000 | -13,733,000 | -125,291,000 | -88,977,000 | 2,601,031,000 | 126,892,000 | 361,068,000 |
| Jun 2025 | 35,544,000 | -17,775,000 | -130,854,000 | -113,985,000 | 2,702,551,000 | 127,427,000 | 387,908,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-290,984,000
Investing CF
$-193,098,000
Financing CF
$423,321,000
CapEx
$-1,350,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-10.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,304,868,000
Inventory
$17,194,000
Receivables
$20,345,000
ST Investments
$753,761,000
EBIT TTM
$-516,321,000
Pretax Income TTM
$-515,615,000
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$156,120,000
EBITDA
$-360,496,000
Free Cash Flow
$-107,751,872
Enterprise Value
$1,794,766,464
Total Cash
$823,105,024
Total Debt
$51,030,000
Shares Out
42,916,593
Trailing EPS
$-10.30
Book Value
$60.79
ROE
-16.1%
ROA
-11.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 147,172,000 | -534,163,000 | -408,351,000 | 2,922,015,000 | 344,153,000 | — | -299,007,000 |
| Dec 2024 | 125,595,000 | -768,222,000 | -2,027,005,000 | 2,983,307,000 | 479,902,000 | — | -577,156,000 |
| Dec 2023 | 93,105,000 | -796,916,000 | -1,465,685,000 | 3,913,814,000 | 267,627,000 | — | -595,800,000 |
| Dec 2022 | 55,550,000 | -742,459,000 | -5,399,098,000 | 4,937,986,000 | 291,825,000 | — | -561,313,000 |
TTM Snapshot
Revenues TTM
$28,652,000
NetIncome TTM
$-125,688,000
OpCashFlow TTM
$0
Assets (Latest)
$2,983,307,000
Forward EPS
$-9.72
Max Pain — expiry 2026-06-18
max pain strike: $60.00 · spot: $58.29 · call oi: 3,654 · put oi: 1,909
Expected Move to 2026-06-18:
±$3.65
(6.26%) —
implied range
$54.64 –
$61.94
· ATM straddle on $60.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACHC | Acadia Healthcare Company, Inc. | $2.30B | $24.99 | — |
| PRVA | Privia Health Group, Inc. | $2.90B | $23.02 | — |
| NHC | NATIONAL HEALTHCARE CORP | $3.06B | $195.59 | — |
| PGNY | Progyny, Inc. | $2.11B | $26.91 | — |
| SEM | SELECT MEDICAL HOLDINGS CORP | $2.06B | $16.65 | — |
News headlines (Yahoo Finance, 1h cache)
Honeywell Stock Is Likely to Reward Shareholders Following Quantinuum IPO, Split
2026-06-04 13:35 · Yahoo
A Look At GRAIL (GRAL) Valuation After A Sharp One Day Share Price Drop
2026-06-02 21:18 · Yahoo
Grail Plummets On Mixed Results For Cancer-Screening Blood Test
2026-06-01 20:32 · Yahoo
GRAIL (GRAL) Is Up 6.7% After Mixed Galleri Trial Data At ASCO 2026 - Has The Bull Case Changed?
2026-06-01 17:12 · Yahoo
GRAIL, Inc. (GRAL): One of the Best Stock Picks of Jeff Bezos
2026-06-01 17:11 · Yahoo
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as AI Optimism Overshadows Middle East Risks
2026-06-01 13:03 · Yahoo
GRAIL’s Galleri Test Cuts Stage 4 Cancer Diagnoses in Study Despite Missed Endpoint
2026-06-01 01:03 · Yahoo
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual
2026-05-31 12:00 · Yahoo
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
2026-05-30 12:00 · Yahoo
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2026-05-27 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.